Detalhe da pesquisa
1.
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.
Blood
; 142(20): 1724-1739, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683180
2.
Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing.
Cytotherapy
; 26(5): 506-511, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483365
3.
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
Mol Cancer
; 22(1): 200, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066564
4.
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
J Hematol Oncol
; 17(1): 19, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644469
5.
Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells.
bioRxiv
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659938
6.
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma.
Transplant Cell Ther
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494076
7.
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.
Blood Adv
; 8(3): 653-666, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113468
8.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Nat Med
; 30(4): 984-989, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266761
9.
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.
Cancers (Basel)
; 16(1)2023 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201531
10.
Apoptosis: a Janus bifrons in T-cell immunotherapy.
J Immunother Cancer
; 11(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055217
11.
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.
bioRxiv
; 2023 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645778
12.
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.
J Exp Clin Cancer Res
; 42(1): 310, 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993874
13.
Treatment strategies for patients with diffuse large B-cell lymphoma.
Cancer Treat Rev
; 110: 102443, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933930
14.
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma.
J Clin Med
; 11(3)2022 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35160279
15.
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
J Clin Med
; 10(6)2021 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799685
16.
Melanoma Brain Metastases in the Era of Target Therapies: An Overview.
Cancers (Basel)
; 12(6)2020 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32575838